Development and techno-economic analysis of Grewia biopolymer-based dual coagulant system for wastewater treatment at pilot scale.
Annual profitability and revenue
Coagulation-flocculation
Laterite suspension
Response surface methodology
Turbidity removal
Journal
Bioresource technology
ISSN: 1873-2976
Titre abrégé: Bioresour Technol
Pays: England
ID NLM: 9889523
Informations de publication
Date de publication:
01 Mar 2024
01 Mar 2024
Historique:
received:
12
12
2023
revised:
27
02
2024
accepted:
29
02
2024
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
3
3
2024
Statut:
aheadofprint
Résumé
Use of Grewia biopolymer as a natural coagulant aid was explored in a dual-coagulant system (conventional coagulant + biopolymer) for wastewater treatment. Such use not only improved turbidity removal efficiency over a wide pH range (5-9) but also helped reducing the concentration demand of inorganic coagulants by 25-50 %. Response surface methodology was employed for investigating the interaction between factors (initial pH, coagulant, and biopolymer concentration) affecting coagulation/flocculation of aqueous laterite suspension, and process optimization for more than 80 % turbidity removal in the desired final pH range (6-7). Mechanisms potentially involved in coagulation/flocculation using biopolymer was elucidated. Techno-economic assessment indicated the feasibility of pilot-scale production of the biopolymer and its use in wastewater treatment. This study demonstrates that Grewia biopolymer has the potential to be used as a coagulant aid and will help researchers select appropriate markets for further cost reduction and successful implementation of biopolymer-based wastewater treatment.
Identifiants
pubmed: 38432546
pii: S0960-8524(24)00217-7
doi: 10.1016/j.biortech.2024.130514
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
130514Informations de copyright
Copyright © 2024. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.